Long-Term Liabilities: The sum of all non-current liabilities.
Aura Biosciences, Inc. (AURA) had Long-Term Liabilities of $14.13M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-106.19M |
|
-- |
|
-- |
|
$112.79M |
|
$-112.79M |
|
$6.71M |
|
$-106.08M |
|
$-106.08M |
|
$-106.19M |
|
$-106.19M |
|
$-106.19M |
|
$-106.19M |
|
$-112.79M |
|
$-111.66M |
|
60.34M |
|
60.34M |
|
$-1.76 |
|
$-1.76 |
|
| Balance Sheet Financials | |
$149.74M |
|
$2.62M |
|
$19.69M |
|
$169.43M |
|
$18.38M |
|
-- |
|
|
Long-Term Liabilities |
$14.13M |
$32.52M |
|
$136.91M |
|
$136.91M |
|
$136.91M |
|
63.59M |
|
| Cash Flow Statement Financials | |
$-84.74M |
|
$35.59M |
|
$77.16M |
|
$32.46M |
|
$60.28M |
|
$27.82M |
|
$14.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-85.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-77.56% |
|
-77.56% |
|
-62.68% |
|
-77.56% |
|
$2.15 |
|
$-1.41 |
|
$-1.40 |
|